US2022249349A1PendingUtilityA1

Moisturizing compositions and uses thereof

64
Assignee: RODAN & FIELDS LLCPriority: Feb 12, 2016Filed: Dec 14, 2021Published: Aug 11, 2022
Est. expiryFeb 12, 2036(~9.6 yrs left)· nominal 20-yr term from priority
A61K 8/042A61Q 19/08A61K 8/736C08L 2205/025C08L 2205/04A61Q 19/005C08B 37/006C08L 5/08C08L 5/04A61K 8/64A61Q 19/007A61K 2800/594A61K 31/327A61K 47/36A61K 8/733A61K 8/731A61K 8/73A61K 47/26A61K 9/0048A61K 9/0014A61Q 19/008C08B 37/0072A61K 45/06A61K 8/732A61P 17/00A61K 8/0245C08L 5/06A61K 8/737A61K 8/735C08L 2205/03C08L 2205/035A61K 9/06C08L 89/00C08L 2203/02A61P 17/16A61Q 19/00A61K 8/60A61K 9/0087A61P 17/02A61K 2800/54A61K 47/42A61K 47/02
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments herein are directed to moisturizing compositions comprising interpenetrating polymer networks, methods of making moisturizing compositions and methods of using moisturizing compositions.

Claims

exact text as granted — not AI-modified
1 - 26 . (canceled) 
     
     
         27 . A method of exfoliating skin comprising administering a topical composition comprising:
 about 61.5% to about 90% of urea and one or more components selected from the group consisting of an active agent, a keratinocyte differentiation promoting agent, a preservative system, an additional humectant, and combinations thereof, and   about 10% to about 38.5% of an interpenetrating polymer network (IPN) composition, wherein the IPN composition comprises:
 about 0.01% w/w to about 5% w/w of crosslinked gellan gum of the IPN composition, 
 about 0.01% w/w to about 5% w/w of cetyl hydroxyethylcellulose of the IPN composition, 
 about 0.01% w/w to about 5% w/w of sodium hyaluronate of the IPN composition, 
 about 0.01% w/w to about 5% w/w of a mono-, or di-valent ion, and 
 about 25% w/w to about 80% w/w of a humectant, of the IPN composition, 
   wherein the cetyl hydroxyethylcellulose and the sodium hyaluronate are interlaced; and   wherein the crosslinked gellan gum is crosslinked via ionic bonds, through the mono-, or di-valent ion, and entraps the interlaced cetyl hydroxyethylcellulose, the sodium hyaluronate, and the humectant to form the interpenetrating polymer network moisturizing topical composition.   
     
     
         28 . The method of  claim 27 , wherein the exfoliation occurs by promoting the digestion of desmosomes, normalizing cell maturation, modulating keratinocyte function, normalizing keratinocyte differentiation, normalizing keratinocyte proliferation, modulating phosphatidylglycerol content of keratinocytes, or any combination thereof. 
     
     
         29 . The method of  claim 27 , wherein the humectant are in an amount of about 30% w/w of the IPN composition. 
     
     
         30 . The method of  claim 29 , wherein the at least one additional humectant is glycerin. 
     
     
         31 . The method of  claim 27 , wherein the mono-, or di-valent ion is selected from the group consisting of 2-Pyrrolidone-5-Carboxylic Acid and related salts including Calcium PCA, Sodium PCA, Zinc PCA, Magnesium PCA, sea salt, inorganic salts of citric acid, inorganic salts of lactic acid, calcium ascorbate, magnesium ascorbate, calcium oxide, calcium benzoate, calcium sorbate, calcium aspartate, magnesium carbonate, magnesium chloride, magnesium nitrate, and any combination thereof. 
     
     
         32 . The method of  claim 27 , wherein the mono-, or di-valent ion is selected from calcium PCA, magnesium PCA, and combinations thereof. 
     
     
         33 . The method of  claim 27 , wherein the humectant is selected from the group consisting of glycerin, diglycerin, betaine, diols, propylene glycol, butylene glycol, pentylene glycol, propanediol, 1,2-hexanediol, D-ribose, glucose, sorbitol, dextrose, urea, 2-Pyrrolidone-5-Carboxylic Acid and related salts, sea salt, inorganic salts of citric acid, inorganic salts of lactic acid, ectoin, lactic acid, betaine, glycolic acid, lactobionic acid, and any combination thereof. 
     
     
         34 . The method of  claim 27 , wherein the topical composition is formulated as a liquid, emulsion, suspension, triturate, adhesive, jelly, foam, paste, ointment, shampoo, cream, serum, milk, lotion, salve, oil, butter, gel, or balm. 
     
     
         35 . The method of  claim 27 , wherein the active agent is selected from the group consisting of a skin treatment, a skin protectant, an acne treatment, a wrinkle treatment, an exfoliating acid, a skin brightening agent, and combinations thereof. 
     
     
         36 . The method of  claim 35 , wherein the acne treatment is selected from the group consisting of benzoyl peroxide, salicylic acid, willowbark extract, poly hydroxyacid, tannic acid, hydroxybenzoic acid, juniperic acid, tartaric acid, glycolic acid, lactic acid, citric acid, and combinations thereof. 
     
     
         37 . The method of  claim 35 , wherein the wrinkle treatment is selected from the group consisting of retinol, antioxidants, vitamin A, retinoid, tretinoin, tazarotene, and combinations thereof. 
     
     
         38 . The method of  claim 35 , wherein the exfoliating acid is selected from the group consisting of glycolic acid, alpha hydroxyl acid (AHA), polyhydroxyacid, and combinations thereof. 
     
     
         39 . The method of  claim 35 , wherein the skin brightening agent is selected from the group consisting of hydroquinone, hexyl resorcinol, phenylethyl resorcinol, and combinations thereof. 
     
     
         40 . The method of  claim 27 , wherein the preservative system is selected from the group consisting of phenoxyethanol, capryl glycol, ethylhexylglycerin, hexylene glycol, sodium benzoate, potassium sorbate, methyl paraben, gluconolactone, lactic acid, sorbic acid, glyceryl caprylate, glyceryl undecylenate, ethanol, chlorphenesin, salicylic acid or any combination thereof. 
     
     
         41 . The method of  claim 27 , wherein the keratinocyte differentiation promoting agent is selected from the group consisting of phosphatidylglycerol, an organic salt of glycerophosphoinositol, calcium PCA, calcium lactate, calcium citrate or other forms of soluble calcium, hydroxyapatite, cortisone, ceramides, ergocalciferol, cholecalciferol, sphingolipids, and any combination thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.